Related Experiment Video

Updated: May 19, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Future directions in osteoporosis therapeutics

Henry Bone1

  • 1Section of Endocrinology and Metabolism, Michigan Bone and Mineral Clinic, St. John Hospital and Medical Center, 22201 Moross Road, Detroit, MI 48236, USA. hgbone.md@att.net

Endocrinology and Metabolism Clinics of North America
|August 11, 2012
PubMed

Insights

Future osteoporosis treatments will target specific pathways like RANK-ligand and Wnt signaling. Combining anabolic and antiresorptive therapies may offer optimal bone health management.

Area of Science:

  • Bone biology and pharmacology
  • Endocrinology and metabolic diseases

Background:

  • Osteoporosis treatment aims to prevent fractures by modulating bone remodeling.
  • Current therapies have limitations, necessitating novel approaches.

Purpose of the Study:

  • To outline future directions in osteoporosis pharmacotherapy.
  • To discuss the integration of anabolic and antiresorptive treatments.
  • To highlight the importance of cost-effectiveness and treatment continuity.

Main Methods:

  • Review of current and emerging therapeutic targets in osteoporosis.
  • Analysis of potential treatment regimens combining different drug classes.
  • Consideration of economic factors and patient adherence.

Main Results:

  • Emerging drug development focuses on precise targets: RANK-ligand, cathepsin K, and Wnt signaling.
  • Anabolic agents and novel antiresorptives offer potential for bone formation preservation.
  • Coordinated anabolic and antiresorptive strategies may optimize bone formation and maintenance.

Conclusions:

  • Future osteoporosis management will likely involve targeted therapies and combination treatments.
  • Emphasis will be placed on cost-effective use of existing medications and ensuring treatment continuity.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...